Once Again, An Important Medication Is Unavailable On The German Market

AbZ Pharma Aliud Pharma Ethypharm Pfizer active ingredient shortage angina pectoris antianginal drug antihypertensive drug bavaria calcium channel blocker cardiac therapy cardiology medication cardiovascular care cardiovascular disease treatment cardiovascular drug cardiovascular tablets chest pain treatment chronic care disruption chronic disease medication clinical medication diltiazem dilzem drug availability drug distribution drug formulation drug import issues drug market disruption drug market germany drug regulator germany drug safety drug shortage drug supply germany essential drug shortage essential medicines europe medication shortage german pharmaceutical market german pharmacies germany germany medication crisis health health authority alert health system stress healthcare healthcare access healthcare crisis healthcare supply healthcare system germany heart disease treatment heart medication high blood pressure treatment hospital pharmacy supply hypertension drug manufacturing issues medical supply chain medical therapy issues medication dependency medication logistics germany medication oversight medication shortage medication stockout medication supply medicine accessibility medicine demand medicine monitoring medicine recall medicine stock medicine unavailability munich november 27 2025 patient care disruption patient health risk patient impact pharma alert pharma distribution issues pharma production pharma supply warning pharmaceutical bottleneck pharmaceutical consumption pharmaceutical delivery problems pharmaceutical demand pharmaceutical logistics pharmaceutical manufacturers pharmaceutical production capacity pharmaceutical regulation pharmaceutical shortage pharmaceutical supply chain pharmacy customers pharmacy demand pharmacy inventory pharmacy shortage prescription availability prescription drug shortage prescription refill problems production delay public health issue retail pharmacy supply supply chain crisis supply crisis supply disruption tablet shortage therapeutic gap therapeutic shortage therapy interruption treatment delay treatment management